Brief: Alembic Pharmaceuticals Got 11 US FDA Product Approvals During June-Quarter
July 3 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS :
* GOT 11 US FDA PRODUCT APPROVALS DURING QUARTER ENDED JUNE 30
* ALEMBIC HAS CUMULATIVE TOTAL OF 206 ANDA APPROVALS FROM US FDA
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand